Benzodiazepine-associated delirium: further considerations

被引：0

作者：

John W. Devlin

Linda M. Peelen

Arjen Slooter

机构：

[1] Northeastern University,School of Pharmacy

[2] Critical Care and Sleep Medicine,Department of Pulmonary

[3] Tufts Medical Center,Julius Center for Health Sciences and Primary Care

[4] University Medical Center Utrecht,Department of Intensive Care Medicine

[5] University Medical Center Utrecht,undefined

来源：

Intensive Care Medicine | 2016年 / 42卷

关键词：

Midazolam; Secondary Analysis; Dexmedetomidine; Oxazepam; Intermittent Administration;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1517 / 1518

页数：1

共 15 条

[1]

Wilson JE(2015)Benzodiazepine-associated delirium dosing strategy or cumulative dose? Intensive Care Med 41 2245-2246

[2]

Brummel NE(2015)Benzodiazepine-associated delirium in critically ill adults Intensive Care Med 41 2130-2137

[3]

Stollings JL(2013)Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit Crit Care Med 41 263-306

[4]

Zaal IJ(2009)Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial JAMA 301 489-499

[5]

Devlin JW(2006)Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients Anesthesiology 104 21-26

[6]

Hazelbag M(undefined)undefined undefined undefined undefined-undefined

[7]

Barr J(undefined)undefined undefined undefined undefined-undefined

[8]

Fraser GL(undefined)undefined undefined undefined undefined-undefined

[9]

Puntillo K(undefined)undefined undefined undefined undefined-undefined

[10]

Riker RR(undefined)undefined undefined undefined undefined-undefined

← 1 2 →